Changing the malaria treatment protocol policy in Timor-Leste: An examination of context, process, and actors' involvement

João S. Martins, Anthony B. Zwi, Karen Hobday, Fernando Bonaparte, Paul M. Kelly

Research output: Contribution to journalArticle

5 Downloads (Pure)


In 2007 Timor-Leste, a malaria endemic country, changed its Malaria Treatment Protocol for uncomplicated falciparum malaria from sulphadoxine-pyrimethamine to artemether-lumefantrine. The change in treatment policy was based on the rise in morbidity due to malaria and perception of increasing drug resistance. Despite a lack of nationally available evidence on drug resistance, the Ministry of Health decided to change the protocol. The policy process leading to this change was examined through a qualitative study on how the country developed its revised treatment protocol for malaria. This process involved many actors and was led by the Timor-Leste Ministry of Health and the WHO country office. This paper examines the challenges and opportunities identified during this period of treatment protocol change.

Original languageEnglish
Article number16
JournalHealth Research Policy and Systems
Issue number1
Publication statusPublished - 15 May 2013


Cite this